Back to search results

TeleABA for Hospitalized Adolescents and Young Adults With Autism Spectrum Disorder

This study is looking at whether adding a program called Telehealth Applied Behavior Analysis (TeleABA) can help adolescents and young adults with autism spectrum disorder (ASD) who are in the hospital for challenging behaviors. You would be randomly assigned to either receive standard hospital care or standard hospital care plus TeleABA. TeleABA uses telehealth (care given remotely, like over video calls) to provide support during your hospital stay and when you go home. Researchers will measure changes in irritability using a tool called the Aberrant Behavior Checklist-Irritability (ABC-I) score. This study is for individuals aged 12 and older with a confirmed ASD diagnosis who are hospitalized for behavioral concerns. The current recruitment status is unclear.

Study design
This is an interventional study that will randomly assign 120 participants to one of two groups: standard hospital care or standard hospital care plus TeleABA.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your ABC-I score will be measured at hospital admission, discharge, and at 2 and 6 weeks after discharge, for up to 365 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07701915

TeleABA for Hospitalized Adolescents and Young Adults With Autism Spectrum Disorder

Not Yet Recruiting
NAAges 12+InterventionalTreatment
Caring Technologies, Inc.
~120 participants
Updated 2026-07-14 on ClinicalTrials.gov
What's tested:Standard Hospital CareTelehealth Applied Behavior Analysis (TeleABA)

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Aberrant Behavior Checklist-Irritability (ABC-I) Score
Measured over Assessed at baseline (hospital admission), at hospital discharge, and at 2 and 6 weeks post-discharge, assessed up to 365 days.

Conditions

Autism Spectrum Disorder (ASD)

Explore related trials

Autism Spectrum Disorder

NCT07701915

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Hackensack Meridian Health Jersey Shore University Medical Center

    Neptune City, New Jerseystudy coordinator listed

  • Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services (CSH-RUCARES)

    Somerset, New Jerseyno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Ron Oberleitner · PRINCIPAL_INVESTIGATOR · Caring Technologies, Inc.
  • Joy Pollard, Ph.D. · PRINCIPAL_INVESTIGATOR · Center for Social Dynamics

Who to contact

Christopher DeBari
[email protected]
732-776-3198
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 12 years or older.
Established or documented diagnosis of autism spectrum disorder (ASD) in the electronic medical record or confirmed by the attending provider using DSM-5 criteria.
Admitted to a participating Hackensack Meridian Health hospital due to behavioral concerns (e.g., aggression, self-injury, elopement, or property destruction) that contribute to or prolong hospitalization.
Behavioral support identified by the attending provider as a primary component of the current admission.
Caregiver or legally authorized representative (LAR) able to provide informed consent.
Patient assent obtained when applicable.
Voluntary, court-mandated, and ward-of-the-state admissions are eligible.

Exclusion

Admission for an acute medical condition in which behavioral concerns are not a primary driver of hospitalization.
Medical instability that precludes participation in telehealth sessions.
Absence of a caregiver or legally authorized representative able to provide informed consent.

What this trial measures

  • Change in Aberrant Behavior Checklist-Irritability (ABC-I) ScoreAssessed at baseline (hospital admission), at hospital discharge, and at 2 and 6 weeks post-discharge, assessed up to 365 days.

    The Aberrant Behavior Checklist-Irritability Subscale is a caregiver-reported measure of irritability, agitation, aggression, tantrums, and self-injurious behavior. Scores range from 0 to 45, with higher scores indicating greater irritability and more severe behavioral symptoms. The primary outcome is the change from baseline in ABC-I score, comparing participants receiving Hospital TeleABA with those receiving standard care.